Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system
ObjectiveThis study aims to investigate the clinical and pathologic characteristics, treatment, and prognosis of primary melanoma in the female reproductive system.MethodsA retrospective analysis was performed using the clinical and pathological data of 33 patients with melanoma of the female lower...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1615749/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849222573883129856 |
|---|---|
| author | Yunge Gao Yunge Gao Jian Dong Ligang Chen Xin Guo Lingling Liu Weinan Guo Cuiling Ma Biliang Chen Jian Wang Xiaohui Lv |
| author_facet | Yunge Gao Yunge Gao Jian Dong Ligang Chen Xin Guo Lingling Liu Weinan Guo Cuiling Ma Biliang Chen Jian Wang Xiaohui Lv |
| author_sort | Yunge Gao |
| collection | DOAJ |
| description | ObjectiveThis study aims to investigate the clinical and pathologic characteristics, treatment, and prognosis of primary melanoma in the female reproductive system.MethodsA retrospective analysis was performed using the clinical and pathological data of 33 patients with melanoma of the female lower genital tract who presented at the Department of Gynecology at Xijing Hospital of Air Force Military Medical University between June 2006 and July 2022. Pathological review and immunohistochemical staining were performed in all cases to confirm the diagnosis.ResultsA total of 15 (45%) cases of primary melanoma involved the vulva, 16 (49%) involved the vagina, and two (6%) involved the cervix. The HMB-45 positive rate was 93%, the S-100 positive rate was 90%, and the Vim positive rate was 100%. Of these 33 cases, we had complete clinical information on 27 of them who received various comprehensive treatments including surgical treatment, postoperative radiotherapy, chemotherapy, immune therapy, or targeted therapy. Patients with stage III–IV comprised 67% of all cases, and the average duration of follow-up was 24 months. The 2-year recurrence rate was 82%, and the 3-year overall survival rate was 42%.ConclusionsThe incidence of melanoma in the female reproductive system is low, and the prognosis is poor owing to the difficulty of early diagnosis and the high possibility of metastasis. Individualized comprehensive treatment like surgical treatment combined with immunotherapy can prolong the survival time and improve the prognosis of patients. |
| format | Article |
| id | doaj-art-8fa953e3e5454c39b3f8ff9f353a7266 |
| institution | Kabale University |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-8fa953e3e5454c39b3f8ff9f353a72662025-08-26T04:13:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-08-011510.3389/fonc.2025.16157491615749Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive systemYunge Gao0Yunge Gao1Jian Dong2Ligang Chen3Xin Guo4Lingling Liu5Weinan Guo6Cuiling Ma7Biliang Chen8Jian Wang9Xiaohui Lv10Department of Obstetrics and Gynecology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Obstetrics and Gynecology, Xi’an People’s Hospital (Xi’an Fourth Hospital), Shannxi, ChinaDepartment of Obstetrics and Gynecology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Obstetrics and Gynecology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Endoscopic Surgery, Air Force 986th Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Dermatology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Dermatology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Dermatology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Obstetrics and Gynecology, Xi’an People’s Hospital (Xi’an Fourth Hospital), Shannxi, ChinaDepartment of Obstetrics and Gynecology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaDepartment of Obstetrics and Gynecology, Xijing Hospital, Air Force Military Medical University, Shannxi, ChinaObjectiveThis study aims to investigate the clinical and pathologic characteristics, treatment, and prognosis of primary melanoma in the female reproductive system.MethodsA retrospective analysis was performed using the clinical and pathological data of 33 patients with melanoma of the female lower genital tract who presented at the Department of Gynecology at Xijing Hospital of Air Force Military Medical University between June 2006 and July 2022. Pathological review and immunohistochemical staining were performed in all cases to confirm the diagnosis.ResultsA total of 15 (45%) cases of primary melanoma involved the vulva, 16 (49%) involved the vagina, and two (6%) involved the cervix. The HMB-45 positive rate was 93%, the S-100 positive rate was 90%, and the Vim positive rate was 100%. Of these 33 cases, we had complete clinical information on 27 of them who received various comprehensive treatments including surgical treatment, postoperative radiotherapy, chemotherapy, immune therapy, or targeted therapy. Patients with stage III–IV comprised 67% of all cases, and the average duration of follow-up was 24 months. The 2-year recurrence rate was 82%, and the 3-year overall survival rate was 42%.ConclusionsThe incidence of melanoma in the female reproductive system is low, and the prognosis is poor owing to the difficulty of early diagnosis and the high possibility of metastasis. Individualized comprehensive treatment like surgical treatment combined with immunotherapy can prolong the survival time and improve the prognosis of patients.https://www.frontiersin.org/articles/10.3389/fonc.2025.1615749/fullfemale reproductive systemmelanomasurgeryimmunotherapycomprehensive treatment |
| spellingShingle | Yunge Gao Yunge Gao Jian Dong Ligang Chen Xin Guo Lingling Liu Weinan Guo Cuiling Ma Biliang Chen Jian Wang Xiaohui Lv Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system Frontiers in Oncology female reproductive system melanoma surgery immunotherapy comprehensive treatment |
| title | Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system |
| title_full | Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system |
| title_fullStr | Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system |
| title_full_unstemmed | Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system |
| title_short | Diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system |
| title_sort | diagnosis and treatment of 33 patients with primary melanoma of the female reproductive system |
| topic | female reproductive system melanoma surgery immunotherapy comprehensive treatment |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2025.1615749/full |
| work_keys_str_mv | AT yungegao diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT yungegao diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT jiandong diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT ligangchen diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT xinguo diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT linglingliu diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT weinanguo diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT cuilingma diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT biliangchen diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT jianwang diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem AT xiaohuilv diagnosisandtreatmentof33patientswithprimarymelanomaofthefemalereproductivesystem |